NCT03788577View on ClinicalTrials.gov

Impact of Oligonol to Cardiometabolic Risk and Muscular Health

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 4, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Muscle LossMuscle WeaknessQuality of Life
Interventions
DIETARY_SUPPLEMENT

Oligonol intake

Major intervention of Oligonol component , as suggested Oligonol safe dose for adults is 200mg per day.

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

112

Taipei Veteran General Hospital, Taipei

All Listed Sponsors
lead

National Yang Ming Chiao Tung University

OTHER

NCT03788577 - Impact of Oligonol to Cardiometabolic Risk and Muscular Health | Biotech Hunter | Biotech Hunter